{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T23:25:51Z","timestamp":1648509951855},"reference-count":50,"publisher":"EDP Sciences","issue":"8-9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1051\/medsci\/2010268-9747","type":"journal-article","created":{"date-parts":[[2011,3,3]],"date-time":"2011-03-03T08:29:32Z","timestamp":1299140972000},"page":"747-752","source":"Crossref","is-referenced-by-count":2,"title":["Immunosuppresseurs et antifongiques"],"prefix":"10.1051","volume":"26","author":[{"given":"Blandine","family":"Rammaert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"250","published-online":{"date-parts":[[2010,8,15]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Gothel SF, Marahiel MA. Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts.Cell Mol Life Sci1999 ; 55 : 423-36.","DOI":"10.1007\/s000180050299"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Ritter ML, Pirofski L. Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity.Transpl Infect Dis2009 ; 11 : 290-7.","DOI":"10.1111\/j.1399-3062.2009.00407.x"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Kahan BD. Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine.Transplant Proc2008 ; 40 : S17-20.","DOI":"10.1016\/j.transproceed.2008.10.019"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function.Annu Rev Immunol1997 ; 15 : 707-47.","DOI":"10.1146\/annurev.immunol.15.1.707"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Schmelzle T, Hall MN. TOR, a central controller of cell growth.Cell2000 ; 103 : 253-62.","DOI":"10.1016\/S0092-8674(00)00117-3"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Allison AC, Eugui EM. Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection.Transplantation2005 ; 80 : S181-S190.","DOI":"10.1097\/01.tp.0000186390.10150.66"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Menzin J, Meyers JL, Friedman M,et al. Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients.Am J Health Syst Pharm2009 ; 66 : 1711-7.","DOI":"10.2146\/ajhp080325"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Lanternier F, Chandesris MO, Poiree S,et al. Cellulitis revealing a cryptococcosis-related immune reconstitution inflammatory syndrome in a renal allograft recipient.Am J Transplant2007 ; 7 : 2826-8.","DOI":"10.1111\/j.1600-6143.2007.01994.x"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Singh N, Lortholary O, Alexander BD,et al. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients.Clin Infect Dis2005 ; 40 : 1756-61.","DOI":"10.1086\/430606"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Lanternier F, Lortholary O. Liposomal amphotericin B: what is its role in 2008?Clin Microbiol Infect2008 ; 14 (suppl 4) : 71-83.","DOI":"10.1111\/j.1469-0691.2008.01984.x"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Steinbach WJ, Reedy JL, Cramer RA, Jr, Perfect JR, Heitman J. Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections.Nat Rev Microbiol2007 ; 5 : 418-30.","DOI":"10.1038\/nrmicro1680"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Odom A, Muir S, Lim E,et al. Calcineurin is required for virulence ofCryptococcus neoformans. EMBOJ1997 ; 16 : 2576-89.","DOI":"10.1093\/emboj\/16.10.2576"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Cruz MC, Sia RA, Olson M, Cox GM. Heitman J. Comparison of the roles of calcineurin in physiology and virulence in serotype D and serotype A strains ofCryptococcus neoformans. Infect Immun2000 ; 68 : 982-5.","DOI":"10.1128\/IAI.68.2.982-985.2000"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Fox DS, Cruz MC, Sia RA,et al. Calcineurin regulatory subunit is essential for virulence and mediates interactions with FKBP12-FK506 inCryptococcus neoformans. Mol Microbiol2001 ; 39 : 835-49.","DOI":"10.1046\/j.1365-2958.2001.02295.x"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Steinbach WJ, Cramer RA, Jr, Perfect BZ,et al. Calcineurin controls growth, morphology, and pathogenicity inAspergillus fumigatus. Eukaryot Cell2006 ; 5 : 1091-103.","DOI":"10.1128\/EC.00139-06"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Steinbach WJ, Cramer RA Jr, Perfect BZ,et al. Calcineurin inhibition or mutation enhances cell wall inhibitors againstAspergillus fumigatus. AntimicrobAgents Chemother2007 ; 51 : 2979-81.","DOI":"10.1128\/AAC.01394-06"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Juvvadi PR, Kuroki Y, Arioka M,et al. Functional analysis of the calcineurin-encoding gene cnaA fromAspergillus oryzae:evidence for its putative role in stress adaptation.Arch Microbiol2003 ; 179 : 416-22.","DOI":"10.1007\/s00203-003-0546-3"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Reedy JL, Filler SG, Heitman J. Elucidating theCandida albicanscalcineurin signaling cascade controlling stress response and virulence.Fungal Genet Biol2010 ; 47 : 107-16.","DOI":"10.1016\/j.fgb.2009.09.002"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Blankenship JR, Wormley FL, Boyce MK,et al. Calcineurin is essential forCandida albicanssurvival in serum and virulence.Eukaryot Cell2003 ; 2 : 422-30.","DOI":"10.1128\/EC.2.3.422-430.2003"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Heitman J. Cell biology. A fungal Achilles\u2019 heel.Science2005 ; 309 : 2175-6.","DOI":"10.1126\/science.1119321"},{"key":"R21","unstructured":"Bastidas RJ, Reedy JL, Morales-Johansson H,et al. Signaling cascades as drug targets in model and pathogenic fungi.Curr Opin Investig Drugs2008 ; 9 : 856-64."},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Bastidas RJ, Heitman J, Cardenas ME. The protein kinase Tor1 regulates adhesin gene expression inCandida albicans. PLoS Pathog2009 ; 5 : e1000294.","DOI":"10.1371\/journal.ppat.1000294"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Cruz MC, Cavallo LM, Gorlach JM,et al. Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs inCryptococcus neoformans. Mol Cell Biol1999 ; 19 : 4101-12.","DOI":"10.1128\/MCB.19.6.4101"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Fitzgibbon GJ, Morozov IY, Jones MG, Caddick MX. Genetic analysis of the TOR pathway inAspergillus nidulans. Eukaryot Cell2005 ; 4 : 1595-8.","DOI":"10.1128\/EC.4.9.1595-1598.2005"},{"key":"R25","unstructured":"Pallet N, Beaune P, Legendre C, Anglicheau D. Rapamycine et inhibition de mTOR : des voies de signalisation aux applications cliniques.Ann Biol Clin (Paris)2006 ; 64 : 107-15."},{"key":"R26","doi-asserted-by":"crossref","unstructured":"O\u2019Gara MJ, Lee CH, Weinberg GA,et al. IMP dehydrogenase fromPneumocystis cariniias a potential drug target.Antimicrob Agents Chemother1997 ; 41 : 40-8.","DOI":"10.1128\/AAC.41.1.40"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Mody CH, Toews GB, Lipscomb MF. Cyclosporin A inhibits the growth ofCryptococcus neoformansin a murine model.Infect Immun1988 ; 56 : 7-12.","DOI":"10.1128\/IAI.56.1.7-12.1988"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Cruz MC, Del Poeta M, Wang P,et al. Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogenCryptococcus neoformansvia cyclophilin-dependent inhibition of calcineurin.Antimicrob Agents Chemother2000 ; 44 : 143-9.","DOI":"10.1128\/AAC.44.1.143-149.2000"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Cruz MC, Goldstein AL, Blankenship J,et al. Rapamycin and less immunosuppressive analogs are toxic toCandida albicansandCryptococcus neoformansvia FKBP12-dependent inhibition of TOR.Antimicrob Agents Chemother2001 ; 45 : 3162-70.","DOI":"10.1128\/AAC.45.11.3162-3170.2001"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"High KP. The antimicrobial activities of cyclosporine, FK506, and rapamycin.Transplantation1994 ; 57 : 1689-700.","DOI":"10.1097\/00007890-199406270-00001"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"High KP, Washburn RG. Invasive aspergillosis in mice immunosuppressed with cyclosporin A, tacrolimus (FK506), or sirolimus (rapamycin).J Infect Dis1997 ; 175 : 222-5.","DOI":"10.1093\/infdis\/175.1.222"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Kirkland TN, Fierer J. Cyclosporin A inhibitsCoccidioides immitisin vitro and in vivo.Antimicrob Agents Chemother1983 ; 24 : 921-4.","DOI":"10.1128\/AAC.24.6.921"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Wong GK, Griffith S, Kojima I, Demain AL. Antifungal activities of rapamycin and its derivatives, prolylrapamycin, 32-desmethylrapamycin, and 32-desmethoxyrapamycin.J Antibiot (Tokyo)1998 ; 51 : 487-91.","DOI":"10.7164\/antibiotics.51.487"},{"key":"R34","doi-asserted-by":"crossref","unstructured":"Oz HS, Hughes WT. Novelanti-Pneumocystis cariniieffects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone.J Infect Dis1997 ; 175 : 901-4.","DOI":"10.1086\/513988"},{"key":"R35","doi-asserted-by":"crossref","unstructured":"Kontoyiannis DP, Lewis RE, Osherov N,et al. Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro inAspergillusspecies.J Antimicrob Chemother2003 ; 51 : 313-6.","DOI":"10.1093\/jac\/dkg090"},{"key":"R36","doi-asserted-by":"crossref","unstructured":"Steinbach WJ, Schell WA, Blankenship JR,et al. In vitro interactions between antifungals and immunosuppressants againstAspergillus fumigatus. Antimicrob Agents Chemother2004 ; 48 : 1664-9.","DOI":"10.1128\/AAC.48.5.1664-1669.2004"},{"key":"R37","doi-asserted-by":"crossref","unstructured":"Steinbach WJ, Singh N, Miller JL,et al. In vitro interactions between antifungals and immunosuppressants againstAspergillus fumigatusisolates from transplant and nontransplant patients.Antimicrob Agents Chemother2004 ; 48 : 4922-5.","DOI":"10.1128\/AAC.48.12.4922-4925.2004"},{"key":"R38","doi-asserted-by":"crossref","unstructured":"Neofytos D, Horn D, Anaissie E,et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.Clin Infect Dis2009 ; 48 : 265-73.","DOI":"10.1086\/595846"},{"key":"R39","doi-asserted-by":"crossref","unstructured":"Almyroudis NG, Sutton DA, Linden P,et al. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature.Am J Transplant2006 ; 6 : 2365-74.","DOI":"10.1111\/j.1600-6143.2006.01496.x"},{"key":"R40","doi-asserted-by":"crossref","unstructured":"Dannaoui E, Schwarz P, Lortholary O. In vitro interaction between antifungals and immunosuppressive drugs against zygomycetes.Antimicrob Agents Chemother2009 ; 53 : 3549-51.","DOI":"10.1128\/AAC.00184-09"},{"key":"R41","doi-asserted-by":"crossref","unstructured":"Marchetti O, Moreillon P, Glauser MP,et al. Potent synergism of the combination of fluconazole and cyclosporine inCandida albicans. Antimicrob Agents Chemother2000 ; 44 : 2373-81.","DOI":"10.1128\/AAC.44.9.2373-2381.2000"},{"key":"R42","doi-asserted-by":"crossref","unstructured":"Onyewu C, Blankenship JR, Del Poeta M, Heitman J. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors againstCandida albicans, Candida glabrata, andCandida krusei. Antimicrob Agents Chemother2003 ; 47 : 956-64.","DOI":"10.1128\/AAC.47.3.956-964.2003"},{"key":"R43","doi-asserted-by":"crossref","unstructured":"Del Poeta M, Cruz MC, Cardenas ME,et al. Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991\/ caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 againstCryptococcus neoformans. Antimicrob Agents Chemother2000 ; 44 : 739-46.","DOI":"10.1128\/AAC.44.3.739-746.2000"},{"key":"R44","doi-asserted-by":"crossref","unstructured":"Kontoyiannis DP, Lewis RE, Alexander BD,et al. Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro againstCryptococcus neoformansisolates: correlation with outcome in solid organ transplant recipients with cryptococcosis.Antimicrob Agents Chemother2008 ; 52 : 735-8.","DOI":"10.1128\/AAC.00990-07"},{"key":"R45","doi-asserted-by":"crossref","unstructured":"Cowen LE, Lindquist S. Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi.Science2005 ; 309 : 2185-9.","DOI":"10.1126\/science.1118370"},{"key":"R46","doi-asserted-by":"crossref","unstructured":"Marchetti O, Entenza JM, Sanglard D,et al. Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due toCandida albicans. Antimicrob Agents Chemother2000 ; 44 : 2932-8.","DOI":"10.1128\/AAC.44.11.2932-2938.2000"},{"key":"R47","doi-asserted-by":"crossref","unstructured":"Husain S, Singh N. The impact of novel immunosuppressive agents on infections in organ transplant recipients and the interactions of these agents with antimicrobials.Clin Infect Dis2002 ; 35 : 53-61.","DOI":"10.1086\/340867"},{"key":"R48","doi-asserted-by":"crossref","unstructured":"Singh N, Alexander BD, Lortholary O,et al. Cryptococcus neoformansin organ transplant recipients: impact of calcineurin-inhibitor agents on mortality.J Infect Dis2007 ; 195 : 756-64.","DOI":"10.1086\/511438"},{"key":"R49","doi-asserted-by":"crossref","unstructured":"Singh N, Aguado JM, Bonatti H,et al. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome.J Infect Dis2009 ; 200 : 1002-11.","DOI":"10.1086\/605445"},{"key":"R50","doi-asserted-by":"crossref","unstructured":"Breton G. Syndrome inflammatoire de reconstitution immune.Med Sci (Paris)2010 ; 26 : 281-9.","DOI":"10.1051\/medsci\/2010263281"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2010268-9747\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T19:17:09Z","timestamp":1637349429000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2010268-9747"}},"subtitle":["Une interaction parfois positive !"],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":50,"journal-issue":{"issue":"8-9"},"alternative-id":["medsci2010268-9p747"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/2010268-9747","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}